(1)
Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review. Rev Diabet Stud 2025, 1039-1048. https://doi.org/10.70082/x94dvz94.